Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yvette C Tanhehco

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 19, 2021
Gene therapy for hemoglobinopathiesYvette C Tanhehco
Clinics in Laboratory Medicine|October 25, 2021
Red Blood Cell TransfusionYvette C Tanhehco
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 4, 2022
Is a universal cure for sickle cell disease imminent?Yvette C Tanhehco
Transfusion|August 27, 2024
Functional biomarkers for sickle cell diseaseYvette C Tanhehco
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 16, 2022
Guest Editors BioYvette C Tanhehco
Transfusion|September 24, 2017
How we manage clinical trials in the cellular therapy laboratoryYvette C Tanhehco, Joseph Schwartz
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 17, 2022
Under the hood: The molecular biology driving gene therapy for the treatment of sickle cell diseaseEvan Waldron, Yvette C Tanhehco
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 27, 2024
Effect of temporary storage of cryopreserved cellular therapy products at -80⁰ celsius on cell recovery and viabilityTobias Cohen, Yvette C Tanhehco
Current Opinion in Hematology|September 5, 2019
Hematopoietic stem cell transplantation and cellular therapy in sickle cell disease: where are we now?Yvette C Tanhehco, Monica Bhatia
Transfusion|June 26, 2020
How the COVID-19 pandemic changed cellular therapy at Columbia University Irving Medical Center/NewYork-Presbyterian HospitalYvette C Tanhehco, Joseph Schwartz
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|January 19, 2021
Gene therapy for hemoglobinopathiesYvette C Tanhehco
Clinics in Laboratory Medicine|October 25, 2021
Red Blood Cell TransfusionYvette C Tanhehco
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 4, 2022
Is a universal cure for sickle cell disease imminent?Yvette C Tanhehco
Transfusion|August 27, 2024
Functional biomarkers for sickle cell diseaseYvette C Tanhehco
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 16, 2022
Guest Editors BioYvette C Tanhehco
Transfusion|September 24, 2017
How we manage clinical trials in the cellular therapy laboratoryYvette C Tanhehco, Joseph Schwartz
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 17, 2022
Under the hood: The molecular biology driving gene therapy for the treatment of sickle cell diseaseEvan Waldron, Yvette C Tanhehco
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 27, 2024
Effect of temporary storage of cryopreserved cellular therapy products at -80⁰ celsius on cell recovery and viabilityTobias Cohen, Yvette C Tanhehco
Current Opinion in Hematology|September 5, 2019
Hematopoietic stem cell transplantation and cellular therapy in sickle cell disease: where are we now?Yvette C Tanhehco, Monica Bhatia
Transfusion|June 26, 2020
How the COVID-19 pandemic changed cellular therapy at Columbia University Irving Medical Center/NewYork-Presbyterian HospitalYvette C Tanhehco, Joseph Schwartz
Pageof 5